MRE-269

TargetMol
Product Code: TAR-T3S2007
Supplier: TargetMol
CodeSizePrice
TAR-T3S2007-5mg5mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3S2007-1mL1 mL * 10 mM (in DMSO)£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3S2007-10mg10mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3S2007-25mg25mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3S2007-50mg50mg£228.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3S2007-100mg100mg£336.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
MRE-269 is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 is used for the treatment of pulmonary arterial hypertension. MRE-269 is an active metabolite of Selexipag (S253150).
CAS:
475085-57-5
Formula:
C25H29N3O3
Molecular Weight:
419.525
Pathway:
Immunology/Inflammation; GPCR/G Protein
Purity:
0.9957
SMILES:
CC(C)N(CCCCOCC(O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1
Target:
Prostaglandin Receptor

References

Sitbon, O., et al.: Eur. Resp. Rev., 21, 321 (2012) Kuwano, K., et al.: J. Pharmacol. Exp. Ther., 322, 1181-1188 (2007) Skoro-Sajer, N., et al.: Expert. Opin. Pharmaco., 15, 429-436 (2014)